Featured
Last news
Ryanair's O'Leary urges pre-flight morning booze ban
Ryanair chief executive Michael O'Leary has urged a ban on serving alcohol in airport bars before morning flights in an effort to tackle drunk and aggressive passengers.
Evacuations 'ongoing' from hantavirus-hit cruise ship
Evacuations were taking place Wednesday from a cruise ship stricken with a deadly outbreak of hantavirus, the World Health Organization said, as experts confirmed a rare strain that can be transmitted between humans.
Cambodian PM's cousin says owned 30% of scam-linked firm
A cousin of Cambodian Prime Minister Hun Manet said Wednesday he owned a 30 percent stake in a digital payments platform linked to cyberscams and money laundering and sanctioned by Washington.
Hegseth's church brings its Christian nationalism to Washington
Pentagon chief Pete Hegseth invited Christian nationalist pastor Doug Wilson, who opposes a woman's right to vote, to preach at the Defense Department earlier this year.
Afrobeats' Tiwa Savage nurtures Africa's future talent
Nigerian Afrobeats sensation Tiwa Savage walked around a music centre in Lagos, smiling, listening and giving words of encouragement to scores of young artists in an elite music training programme.
Bondi Beach mass shooting accused faces 19 extra charges
A man accused of murdering 15 people in an antisemitic mass shooting at Australia's Bondi Beach is facing a raft of fresh charges, court records released Wednesday showed.
Judge orders German car-ramming suspect to psychiatric hospital
A man suspected of ploughing a car into a crowd in the German city of Leipzig, killing two people, was ordered into a psychiatric hospital by a judge on Tuesday.
Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Zomedica surpasses $8 million in first quarter revenue for the first time and delivers record year-over-year revenue for 21st straight quarter.
Pivotree Announces Resignation of Board Director Patrick Meneley
TORONTO, ON / ACCESS Newswire / May 6, 2026 / Pivotree Inc. (TSXV:PVT) ("Pivotree" or the "Company") today announced that Patrick Meneley has resigned as a member of the Company's Board of Directors, effective immediately.
Vanta Announces Closing of Second Tranche of Private Placement for Aggregate Gross Proceeds of $1 Million
VANCOUVER, BC / ACCESS Newswire / May 6, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta premium hydration and longevity brand, announces that, further to its news release dated May 5, 2026, the Company has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement").
Rythmia Residences Launches in Costa Rica, Introducing a First-of-Its-Kind Conscious Living Community Integrated with the Rythmia Life Advancement Center
TAMARINDO, COSTA RICA / ACCESS Newswire / May 6, 2026 / Rythmia Life Advancement Center, a globally recognized leader in transformational wellness experiences, today announced the official launch of Rythmia Residences, a private luxury residential community designed to integrate world-class wellness into everyday living.
Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
Pediatric patients with Intestinal Failure (IF) due to MVID, an ultrarare congenital disorder with lethal natural history, that has no available therapies and needs lifelong total Parenteral Support (PS), could benefit from expedited development of oral crofelemer via Breakthrough Therapy DesignationCrofelemer has demonstrated meaningful reductions in weekly PS needs in two pediatric MVID patients with initial results to be presented at ESPGHAN 2026
Musk 'was going to hit me,' OpenAI executive says at trial
OpenAI President Greg Brockman told a California jury Tuesday that Elon Musk physically threatened him during a 2017 confrontation, testifying that the billionaire stormed out after he was refused absolute control of the artificial intelligence company.
G7 trade ministers meet, not expected to discuss US tariff threat
G7 trade ministers opened a meeting in Paris on Tuesday to discuss issues including critical minerals, but were not expected to directly address the latest US threat to impose additional tariffs on European vehicles.
German car-ramming suspect had mental health problems: reports
A man suspected of ploughing a car into a crowd in the eastern German city of Leipzig, killing two people, had recently been treated for mental health problems, reports said Tuesday.
China fireworks factory explosion kills 26, injures 61
The death toll from a giant explosion at a fireworks factory in central China rose to 26, with 61 more injured, officials said Tuesday.
Sherlock Holmes fans recreate fateful duel at Swiss falls
Immaculately dressed in Victorian costume, Sherlock Holmes devotees gathered at the Reichenbach Falls in Switzerland to recreate the intrepid detective's fateful duel with his nemesis Professor Moriarty, 135 years on.
Trouble in paradise: Colombia tourist jewel plagued by violence
With snow-capped mountains sweeping down to the turquoise waters of the Caribbean, Sierra Nevada de Santa Marta National Park is one of the jewels in Colombia's tourism crown.
Death toll in Brazil small plane crash rises to three
Three people died and two others were injured Monday after a small plane crashed into a residential building in the major Brazilian city of Belo Horizonte.
Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
VANCOUVER, BC / ACCESS Newswire / May 5, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta premium hydration and longevity brand, announces that, further to its news releases dated January 29, 2026 and March 25, 2026, the Company has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") and closed its previously announced debt settlement (the "Debt Settlement"), on the terms described herein.
Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation
VANCOUVER, BC / ACCESS Newswire / May 5, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that Inka Health Corp. ("Inka Health"), the Company's wholly owned subsidiary, has started a collaborative research agreement (the "Agreement" or "Project" or "Work") with GlaxoSmithKline LLC ("GSK"). Under the Agreement, Inka Health and GSK intend to collaborate to develop real-world data-driven methodologies aimed at improving the transportability of oncology clinical trial results across broader patient populations, geographies, and healthcare settings, with a view to helping to make clinical evidence more relevant to real-world decision-making.
Viemed Healthcare Announces First Quarter 2026 Financial Results
LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months ended March 31, 2026, and updated guidance for the full year ending December 31, 2026.
AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line
Industry veteran brings deep CRO and biopharma expertise from ICON, PRA Health Sciences, and Covance to accelerate growth and operationalization of AMC Health's DCT platform
Birthday girl, 10, among dead in Colombia monster truck crash
A Colombian girl celebrating her 10th birthday was among three people crushed to death at a monster truck display when a vehicle veered out of control and plowed into spectators, authorities said Monday.
Broadway theater blaze forces 'Book of Mormon' to close
A blaze caused major damage Monday to Broadway's storied Eugene O'Neill Theater, forcing it to close for repairs and halting its run of the smash hit musical "The Book of Mormon," the New York fire department said.
Swastikas daubed on NY Jewish homes, synagogues: police
Antisemitic graffiti including swastikas has been spray-painted onto Jewish homes, synagogues and a memorial commemorating Kristallnacht, New York police and city officials confirmed Monday, with the incidents being investigated as possible hate crimes.
Health emergency on the MV Hondius: what we know
Three passengers who were cruising the Atlantic Ocean on the MV Hondius have died, with one other person on the trip now in hospital with hantavirus, and two crew ill.
GameStop makes $56 billion takeover bid for eBay
US video game retailer GameStop made a takeover bid on Sunday to buy eBay for about $55.5 billion in an attempt to turn the online marketplace into a competitor to e-commerce giant Amazon.
'No pilgrims': regional war hushes Iraq's holy cities
In Iraq's holy city of Najaf, the majestic shrine of Imam Ali stands quiet, its vast courtyards no longer echoing with the multilingual whispers of pilgrims from before the Middle East war.
Avant Brands Announces Voting Results from Its 2026 Annual General and Special Meeting of Shareholders
KELOWNA, BC / ACCESS Newswire / May 4, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce the voting results from its annual general and special meeting (the "Meeting") of the shareholders of the Company (the "Shareholders") held on May 4, 2026.
Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health
Neonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool formation, gut hydration, and bowel healthExpansion builds on Jaguar's focus on sustainably derived, plant-based gastrointestinal products for people and animals
NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA
SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that its clinical stage, broad-spectrum, antiviral drug NV-387 has been granted an "Orphan Drug Designation" (ODD) by the US FDA Office of Orphan Products Development (OOPD).